SCHEMBL22904129

SCHEMBL22904129

O=C1Cc2cccc(Oc3ccccc3Cl)c2C(=O)N1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.54
TDP2 O95551 8/20 0.51
CASP3 P42574 1/20 0.45
CASP7 P55210 1/20 0.45
CASP9 P55211 1/20 0.45
CASP6 P55212 1/20 0.45
CASP8 Q14790 1/20 0.45
MAP3K14 Q99558 1/20 0.45
GRIA1 P42261 3/20 0.42
CACNG8 Q8WXS5 3/20 0.42
PDK2 Q15119 1/20 0.40
CACNG2 Q9Y698 1/20 0.40
RHEB Q15382 1/20 0.40
HPGD P15428 1/20 0.38
LDHA P00338 1/20 0.38
PGR P06401 1/20 0.37
HTR1A P08908 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22904128 0.83 TDP2 (0.51) AHRTDP2CASP3CASP7CASP9
SCHEMBL22904252 0.83 TDP2 (0.51) AHRTDP2CASP3CASP7CASP9
SCHEMBL22904393 0.83 TDP2 (0.51) AHRTDP2CASP3CASP7CASP9
SCHEMBL22904103 0.83 TDP2 (0.51) AHRTDP2CASP3CASP7CASP9
SCHEMBL11089493 0.82 AHR (0.71) AHRTDP2CASP3CASP7CASP9
SCHEMBL22904525 0.82 TDP2 (0.54) AHRTDP2CASP3CASP7CASP9
SCHEMBL22904285 0.82 TDP2 (0.50) AHRTDP2CASP3CASP7CASP9
SCHEMBL22904275 0.80 TDP2 (0.48) AHRTDP2CASP3CASP7CASP9
SCHEMBL22904356 0.80 TDP2 (0.48) AHRTDP2CASP3CASP7CASP9
SCHEMBL29794338 0.80 TDP2 (0.48) AHRTDP2CASP3CASP7CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011631-A1 FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed